ProQR Therapeutics N.V.

NASDAQ: PRQR · Real-Time Price · USD
2.04
0.02 (0.99%)
At close: Aug 15, 2025, 3:59 PM
2.05
0.24%
After-hours: Aug 15, 2025, 04:10 PM EDT

ProQR Therapeutics Cash Flow Statement

Financials in EUR. Fiscal year is January - December.
Fiscal Year Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-10.08M -9.3M -8.11M -2.71M -7.7M -5.34M -5.42M -7.98M -8.86M -11.39M -24.38M -14.67M -14.45M -18.24M -15.07M -15.75M -12.62M
Depreciation & Amortization
678K 671K 688K 711K 691K 709.32K 642K 594K 549K 748K 612K 591K 570K 552K 544K 602K 631K
Stock-Based Compensation
758K 568K 612K 628K 736K 802K 444K 765K 1.09M -387K 1.33M 738K 1.18M 1.78M 1.72M 1.47M 1.25M
Other Working Capital
-6.72M -543K 1.12M -4.61M -9.22M 2.3M -2.01M -3.62M n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Non-Cash Items
-434K -739K 34K -75.39K 320K -3.37M -1.08M -571K -354K -1.04M 3.54M -2.34M -3.72M 333K 87K 1.73M 319K
Deferred Income Tax
n/a n/a n/a -200K 3K 5K -83K 464K n/a -96K 69K 20K 7K 22K 35K 53K 7K
Change in Working Capital
-6.72M -543K 1.12M -4.61M -9.28M 2.3M -2.01M -3.62M 52.29M -5.67M 3.46M 820K -4.05M 19.34M 4.63M 1.92M -1.35M
Operating Cash Flow
-15.8M -9.35M -5.66M -6.26M -15.13M -5.32M -7.51M -10.35M 44.73M -17.83M -15.36M -14.84M -20.47M 3.79M -8.06M -9.98M -11.76M
Capital Expenditures
-224K -133K -286K -262.33K -736.31K -2.87M -339K -294K -136K 13K -246K -231K -244K -225K -175K -52K -32K
Cash Acquisitions
n/a n/a n/a n/a n/a 12.14K -22.42 663.52 46.53K 5.72K n/a n/a n/a 59.33K n/a n/a n/a
Purchase of Investments
n/a n/a n/a 139.89K -17.1M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a 17M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Investing Acitivies
n/a -2.65M n/a -144.56K n/a 5.6M 22.42 -663.52 472.00 281.41 n/a n/a n/a 59K n/a n/a n/a
Investing Cash Flow
-224K -2.79M 16.71M -267K -17.73M 5M -339K -294K -89K 19K -246K -231K -244K -166K -175K -52K -32K
Debt Repayment
-567K -253K -454K -294K -581K -1.29M -432K -647K -259K -359K -43.75M -357K -576K 26.58M -63K 555K -236K
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
67K 71.68M 1K 12K 162K 240.33K 151K 4K n/a 1K n/a n/a 33K 363K 402K 185K 569K
Financial Cash Flow
-500K 71.43M -453K -282K -419K -1.09M -281K -643K -259K 13.76M -43.75M -357K -543K 26.94M 23.56M 83.34M 2.98M
Net Cash Flow
-16.99M 60.01M 10.43M -6.74M -33.21M -1.63M -8.01M -10.42M 44.21M -5.66M -55.97M -11.21M -19.91M 31.38M 16.7M 71.56M -7.96M
Free Cash Flow
-16.02M -9.48M -5.94M -6.52M -15.96M -8.36M -7.85M -10.64M 44.59M -17.82M -15.61M -15.07M -20.71M 3.56M -8.23M -10.03M -11.79M